Enzyme–substrate reporters for evaluation of substrate specificity of HIF prolyl hydroxylase isoforms


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

An organism naturally responds to hypoxia via stabilization of hypoxia-inducible factor (HIF). There are three isoforms of HIFα subunits whose stability is regulated by three isozymes of HIF prolyl hydroxylase (PHD1-3). Despite intense studies on recombinant enzyme isoforms using homogeneous activity assay, there is no consensus on the PHD iso-form preference for the HIF isoform as a substrate. This work provides a new approach to the problem of substrate specificity using cell-based reporters expressing the enzyme and luciferase-labeled substrate pair encoded in the same expression vector. The cell is used as a microbioreactor for running the reaction between the overexpressed enzyme and substrate. Using this novel approach, no PHD3 activity toward HIF3 was demonstrated, indirectly pointing to the hydroxylation of the second proline in 564PYIP567 (HIF1) catalyzed by this isozyme. The use of “paired” enzyme–substrate reporters to evaluate the potency of “branched tail” oxyquinoline inhibitors of HIF PHD allows higher precision in revealing the optimal structural motif for each enzyme isoform.

Об авторах

A. Osipyants

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Россия, Moscow, 117997

N. Smirnova

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Россия, Moscow, 117997

A. Khristichenko

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Россия, Moscow, 117997

D. Hushpulian

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Россия, Moscow, 117997

S. Nikulin

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Россия, Moscow, 117997

T. Chubar

Lomonosov Moscow State University, Chemistry Faculty

Email: igazaryan@gmail.com
Россия, Moscow, 119991

A. Zakhariants

Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Россия, Moscow, 109451

V. Tishkov

Lomonosov Moscow State University, Chemistry Faculty; Innovations and High Technologies MSU Ltd.

Email: igazaryan@gmail.com
Россия, Moscow, 119991; Moscow, 109451

I. Gazaryan

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology; Lomonosov Moscow State University, Chemistry Faculty

Автор, ответственный за переписку.
Email: igazaryan@gmail.com
Россия, Moscow, 117997; Moscow, 119991

A. Poloznikov

Rogachev National Medical Research Center for Pediatric Hematology, Oncology and Immunology

Email: igazaryan@gmail.com
Россия, Moscow, 117997


© Pleiades Publishing, Ltd., 2017

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах